2024 International Congress Archives - Page 166 of 181

A 24-year-old female with 18p deletion syndrome presenting with rapidly worsening dystonia

P. Hoang, T. Stiep (San Francisco, USA)
A 3D CNN Approach for the Classification of Multiple System Atrophy using Multimodal Multicentric MRI

GM. Mattia, L. Chougar, WG. Meissner, A. Foubert-Samier, A. Pavy-Le Traon, O. Rascol, M. Fabbri, S. Lehéricy, P. Péran (Toulouse, France)
A Benign Course of Parkinson’s Disease Associated with Different Mutations in the Glucocerebrosidase (GBA) Gene – a Case Series.

M. Cohen, Y. Schechter, R. Eichel, G. Yahalom (Jerusalem, Israel)
A better understanding of Paediatric Paroxysmal Movement Disorders

S. Harvey, N. Allen, S. Byrne, B. Lynch, N. Mcsweeney, S. Neville, O. O'Mahony, M. O'Regan, D. O'Rourke, E. Reade, D. Webb, M. King, K. Gorman (Dublin, Ireland)
A Case of Concurrent Wilson Disease and Parkinson Disease

C. Tapia, M. Davis, M. Penon-Portmann, S. Hahn, E. Rezvanian (Seattle, USA)
A case of malignant Deep Brain Stimulation Withdrawal Syndrome treated with Opicapone

D. Brogle, L. Zünd-Hofer, F. Brugger, G. Kägi (Sankt Gallen, Switzerland)
A Case of Paradoxical Gait Response to Levodopa in Parkin-Gene-Related Early-Onset Parkinson’s Disease

D. Naheed, A. Mehta, S. Neo, L. Tan (Singapore, Singapore)
A case of progressive supranuclear palsy followed by dementia with Lewy bodies

S. Fujita, H. Kawasaki, R. Yokoyama, Y. Ito, T. Yamamoto (Muroyama-cho, Japan)
A case of Restless Abdominal Syndrome An Uncommon Variant of Restless Leg Syndrome

M. Avanaki, D. Salzman (Weston, USA)
A Comparative Bioavailability Study between a Marketed Capsule-based Levodopa Dry Powder Inhaler and a New Pre-filled Levodopa Dry Powder Inhaler

T. van Laar, F. Grasmeijer, M. Hoppentocht (Groningen, Netherlands)
A comparative study of focused ultrasound unilateral thalamotomy and subthalamotomy for medication refractory Parkinsonian tremor

S. Paschen, E. Natera, J. Pineda-Pardo, M. Del Alamo, R. Rodríguez-Rojas, G. Deuschl, J. Obeso, AK. Helmers, R. Martínez Fernández (Kiel, Germany)
A comprehensive at-home and in-hospital work-up of patients with Parkinson’s disease receiving fosflevodopa/fosfcarbidopa continuous subcutaneous infusion

G. Lazzeri, C. Baiata, F. Del Sorbo, M. Corradi, M. Barichella, L. Caffi, C. Palmisano, P. Soliveri, G. Pezzoli, IU. Isaias (Milan, Italy)
A Comprehensive Evaluation of the Non-Motor Symptoms, Quality of Life and Caregiver Burden in Patients with Idiopathic Dystonia

N. Gowda, N. Kamble, VV. Holla, R. Yadav, B. Muthusamy, PK. Pal (Bengaluru, India)
A Conversational GPT Agent for Parkinson’s Disease

B. Várkuti, L. Manola, M. Atayi, L. Liemen, G. van Elswijk, F. Lange, M. Reich, L. Erōss, M. Okun, J. Volkmann (München, Germany)
A Cross-Sectional Study of Sleep Disturbances in Parkinson’s Disease Patients at a Tertiary Neurological Center in Nepal

AYU. Chandra, AVI. Chandra (Tianjin, China)
A Curious Case of Bilateral Hemifacial Spasm after Treatment of Acne Vulgaris

C. Selvadurai, A. Zulfi, M. Portley (Farmington, USA)
A Curious Case of Copper de-Compensation

D. Tang, CH. Tan, SF. Woo, D. Soon, J. Tan (Singapore, Singapore)
A Device Agnostic Pipeline for Gait Detection and Assessment in Free-living and Clinical Environments

B. Cornish, K. Beyer, K. Weber, A. Vert, K. van Ooteghem, W. Mcilroy (Waterloo, Canada)
A Double-blind, Randomized, Crossover Clinical Trial comparing VIM vs. PSA Deep Brain Stimulation for Disabling Essential Tremor

L. Triguero-Cueva, CJ. Madrid Navarro, MJ. Perez Navarro, B. Iáñez Velasco, JP. Martínez Barbero, B. Marín-Romero, A. Mínguez-Castellanos, F. Escamilla-Sevilla, M. Jouma Katati (Granada, Spain)
A group of patients with multiple system atrophy (MSA) exhibit cardiac sympathetic dysfunction to the same extent as Parkinson’s disease (PD).

R. Yokoyama, T. Yamamoto (Moroyama, Japan)
A Head-Turning Case of SCA10 with Dystonia

S. Marmol, V. Armengol, D. Shpiner (Miami, USA)
A Homozygous Variant in NAA60 is Associated with Primary Familial Brain Calcification

X. Chen, Y. Shi, F. Fu, L. Wang, D. Yang, X. Wang, C. Ying, H. Wang, Z. Lin, H. Wang, F. Zhang, X. Zheng, Y. Guo, Y. Wang, Y. Zeng, M. Zhao, Y. Chen, J. Li, H. Xia, J. Chen, B. Wang, S. Wu, F. Xie, J. Feng, Z. Cen, W. Luo (Hangzhou, China)
A Kinematic and fMRI Study of the Neural Correlates of Bradykinesia in Parkinson’s Disease

E. Sarasso, A. Gardoni, L. Zenere, D. Emedoli, R. Balestrino, A. Grassi, S. Basaia, C. Tripodi, E. Canu, M. Malcangi, E. Pelosin, MA. Volontè, D. Corbetta, M. Filippi, F. Agosta (Milan, Italy)
A Machine Learning Approach for Early Identification of Prodromal Parkinson’s Disease

A. Vaish (Redmond, USA)
A matching-adjusted indirect comparison of efficacy and safety for safinamide versus rasagiline as adjunctive treatment to levodopa in Chinese patients with Parkinson’s disease

Y. Tan, Q. Wei, P. Xu, E. Tao, L. Wang, C. Cattaneo, H. Shang, S. Chen (Shanghai, China)
A Network Analysis shows How Impulsive-Compulsive Behaviors correlates with Levodopa-Induced Dyskinesia

B. Veiga, C. Silva, S. Silva, R. Saba, H. Ferraz, V. Borges (São Paulo, Brazil)
A new phenotype-genotype correlation for FIG4 gene and Parkinson’s disease

I. Boura, G. Xiromerisiou, I A. Giannopoulou, P. Mitsias, C. Spanaki (HERAKLION, Greece)
A Nomogram Model for Predicting Malnutrition among Patients with Parkinson’s Disease

Q. Huang, X. Zou (Chengdu, China)
A non-linear index can detect early postural instability in people with Parkinson’s disease: Enhancing perspectives on the utilization of cost-effective technologies.

G. Santos, M. D'Alencar, A. Frazão, A. Roque, J. Vivas, M. Piemonte (São Paulo, Brazil)
A novel G413S mutation in the CSF1R gene causes Hereditary Diffuse Leucoencephalopathy with axonal Spheroids; clinically overlapping features of Parkinsonism

ANW. Ullah, MZB. Badshah (Peshawar, Nepal)
A Novel Mutation of NKX2-1 Gene: A Rare Presentation of Chorea

BC. Ari, S. Canbek, G. Kenangil (ISTANBUL, Turkey)
A Novel Peer Mentoring Support System for Persons with Parkinson’s Disease

E. Lubas, TW. Liang, K. Stoveld, SK. Thurman (Philadelphia, USA)
A novel single-cell reporter identifies regulators of the endogenous PINK1-Parkin mitochondrial quality control pathway

J. Thayer, X. Huang, J. Hawrot, D. Ramos, M. Ward, D. Narendra (BETHESDA, USA)
A Novel SLC9A1 Mutation Associated with Cerebellar Ataxia and Sensorineural Hearing Loss

S. Dharmadhikari, Y. Kianirad (Chicago, USA)
A pathology-validated study to investigate the role of Uric Acid in Parkinson’s Disease

P. Pecoraro, S. Carbone, V. Di Lazzaro, L. Di Biase (Rome, Italy)
A Patient with Overlapping SPG7 mutation and MERRF

J. Patino, M. Koenig (Houston, USA)
A Phase 1b Randomized, Placebo-Controlled, Delayed-Start Trial of UB-312 in Synucleinopathies.

P. Millar Vernetti, D. Mirski, JC. Dodart, A. Wood, HJ. Yu, J. Boyd, P. Kundu, R. Setton, D. Silbersweig, E. Stern, C. Lucero, S. Gerrol, H. Kaufmann, J. Martinez (New York, USA)
A Phase 2 Randomized Clinical Trial of TAK-071, an Acetylcholine M1 Receptor Positive Allosteric Modulator, in Parkinson Disease with Cognitive Impairment

N. Shanbhag, J. Padmanabhan, Z. Zhang, B. Harel, H. Jia, T. Kangarloo, W. Yin, A. Dowling, A. Laurenza, P. Khudyakov, K. Galinksy, R. Latzman, T. Simuni, D. Weintraub, F. Horak, C. Lustig, P. Maruff, A. Simen (Cambridge, USA)
A Phase 2 Study of ATH434 a Novel Inhibitor of α-Synuclein Aggregation for the Treatment of Multiple System Atrophy

D. Stamler, C. Wong, P. Trujillo, M. Bradbury, C. Lucas, D. Claassen (Newark, USA)
A Phase 2b Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of OnabotulinumtoxinA for the Treatment of Upper Limb Essential Tremor: ELATE Trial

K. Patterson, N. Alibhai, D. Khosla, L. James (North Chicago, USA)
A Phase IIb Double-Blind Placebo-Controlled Randomized Cross-Over Clinical Trial of Sodium Oxybate in Isolated Focal Laryngeal Dystonia

L. O'Flynn, A. Hamzehei Sichani, S. Frucht, A. Rumbach, N. Sharma, P. Song, A. Worthley, K. Simonyan (Boston, USA)
A Pilot Study of Intrajejunal Faecal Microbiota Transplant to Improve Motor Function in Patients with Parkinson’s Disease Treated with Levodopa-carbidopa Intestinal Gel: Preliminary Findings.

D. Wilson, L. Williams, S. Waller, S. Dal, J. Qiu, D. Tsui, S. Bray, J. Griffith, D. Galea, X. Chen, F. Tudehope, L. Bracken, H. Morales-Briceno, N. Mahant, F. Chang, S. Bandodkar, D. Van-Der-Poorten, V. Fung (Sydney, Australia)
A Poor Prognosis for Acute Post Hypoxic Myoclonus with Status Epilepticus: A Case Report

A. Kurniadi (Kabupaten Bekasi, Indonesia)
A Post Hoc Efficacy Analysis of Phase 3 Trials of Continuous Subcutaneous Foslevodopa/Foscarbidopa in Patients With Parkinson’s Disease

M. Soileau, M. Bouchard, I. Malaty, J. Parra, L. Bergmann, R. Gupta, A. Spiegel, E. Freire-Alvarez (Georgetown, USA)
A Post-mortem Study on Striatal Glia and Blood Brain Barrier Integrity in Aging and PD Asian-Indians.

H J. Jyothi, A. Mahadevan, U. Muthane, T C. Yasha, P. Alladi (Bengaluru, India)
A Preliminary Report on the Clinical Profile of People with PD at an Outpatient Clinic in Malawi

M. Gwedela, T. Phiri (Blantyre, Malawi)
A prospective study on post-stroke Holmes tremor with analysis of semiology, lesion topography and treatment outcomes

A. Datta, A. Mukherjee, A. Biswas (Kolkata, India)
A Prospective, Multicenter, Single-Arm Feasibility Study Examining ECAP-Controlled, Closed-Loop Spinal Cord Stimulation for Parkinson’s Disease (eCAP-PD): Technical and Design Considerations

L. Verhagen, T. Virmani, M. Pourfar, C. Hess, J. Rosenow, E. Petersen, A. Mogilner, J. Karl, N. Shetty (Chicago, USA)
A Quantitative Investigation has Revealed Nifedipine as a Possible Pharmacological Modulator in Parkinson’s Disease

G. Kuanar, C. Mahapatra (Cuttack, India)
A Randomized, Double-blind, Phase 2a Clinical Trial to Study the Efficacy and Safety of Lamotrigine for Treatment of Patients with Dementia with Lewy Bodies

T. Xi, S. Kang, F. Kim, A. Schindler, D. Greeley, J. Choung, M. Yun, B. Ye (San Diego, USA)
A Randomized, Double-Blind, Placebo-Controlled Trial of a Multi-Strain Probiotic for Anxiety in Parkinson’s Disease

J. Lam, P. Uzelman, J. Zhu, D. Meng, F. Pio, S. Appel-Cresswell (Vancouver, Canada)
A Rare Case of Hemicorea Secondary to Giant Perivascular Space: A Case Report

M. Merscher, C. Lobo, V. de Souza, R. Souza, R. Helmer, L. Pinho, L. Urzeda, W. Machado-Filho, T. Ganho, W. Avelar (Campinas, Brazil)
A Rare Case of Parkinson’ s Disease Associated With Heterozygous ATP13A2 Gene Mutation: What If There Are No Atypical Features with a Later Onset?

Y. Degirmenci (Istanbul, Turkey)
A Rare Case Of Young Onset Ataxia: Spinocerebellar Ataxia Type 40

Y. Degirmenci (Istanbul, Turkey)
A Rare Manifestation of Oculogyric Crisis in Schizophrenia Patients with Risperidone: Case Series

D. Siregar, D. Tunjungsari, A. Tiksnadi, E. Hanafi (Jakarta Pusat, Indonesia)
A Review of the Genetic Spectrum of Hereditary Spastic Paraplegias in the Middle East and North Africa Region

M. Salari, S. Soleimani, F. Hojjati Pour (Tehran, Islamic Republic of Iran)
A Risk of Thromboembolic Complications In Patients With Parkinson’s Disease

P. Lisewski, B. Lisewska, N. Słomka, M. Wasilewska, D. Rość (Bydgoszcz, Poland)
A Scoping Review of Epidural Spinal Cord Stimulation in the Treatment of Multiple Movement Disorder Symptoms

D. Megan, J. Kramer, L. Venkatesan (Harrogate, United Kingdom)
A Study of Age-related Changes in Galanin Expression in the Neuropil and Associated Boutons in the Human Locus Coeruleus.

S. Banik, A. Bhattacharya, A. Mahadevan, Y. Tc, P. Alladi (Bengaluru, India)
A study on the phenomenological analysis of Spinocerebellar Ataxia type 12 revealing a dystonic imprint

A. Mukherjee, S. Pandey (Faridabad, India)
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants with Early Parkinson’s Disease (PADOVA): Rationale, Design, and Baseline Data

T. Nikolcheva, G. Pagano, N. Pross, T. Simuni, K. Marek, R. Postuma, N. Pavese, F. Stocchi, K. Seppi, G. Respondek, A. Monnet, N. Shariati, L. Rutten-Jacobs, T. Kustermann, K. Taylor, D. Trundell, H. Svoboda, A. Bonni, P. Fontoura, R. Doody (Basel, Switzerland)
A Successful Case of Bilateral GPi Rescue DBS in Dystonic Tremor Following Tremor Re-emergence After Previous Bilateral PSA DBS Five Years Prior

I. Osborne, J. Peters, J. Maamary, Y. Barnett, B. Jonker, S. Tisch (Sydney, Australia)
A Survey of Immunological Mechanisms in Cervical Dystonia

L. Scorr, G. Kilic-Berkmen, J. Mckay, D. Sutcliffe, A. Mckeon, H. Jinnah (Atlanta, USA)
A Systematic Review of Action Observation Therapy for Parkinson’s Disease Rehabilitation

A. Abdelhamed, M. Fahmy, H. Samy, H. Hesham, M. Zakzouk, R. Elsayed, S. Elwaly, M. Walid, R. Hesham, M. Khaled, M. Boshra, M. Saleh (Giza, Egypt)
A Systematic Review of Transcranial Magnetic Stimulation Clinical Trials in Parkinson’s Disease Patients with Mild Cognitive Impairment

S. Baveja, R. Rajmohan, N. Phielipp (Orange, USA)
A telehealth physical activity coaching program can maintain physical activity and exercise confidence in people with Parkison disease: a cohort study.

D. Wani, A. Chandrana, A. Pacheco, D. Kipnis, J. Alomar, C. Macpherson, J. Fineman, L. Quinn (New York, USA)
A UK-wide Effort for Identification of Loci for Autosomal Dominant Parkinson’s Disease

R. Tilney, R. Real, S. Jasaityte, Z. Fang, M. Fenn, L. Lange, A. Singleton, C. Blauwendraat, C. Klein, H. Morris, GP2. Genetic Program (London, United Kingdom)
A Unique case of Ataxia, Neuropathy, and chronic cough: CANVAS

R. Vasireddy, Y. Sun (Lexington, USA)
A Visual Interpretation Algorithm for Assessing 18F-Florzolotau PET Scans in Progressive Supranuclear Palsy

F. Liu, J. Wang, C. Zuo (Shanghai, China)
AAV-mediated gene therapy for GBA-PD

S. Ayloo, J. Ryu, S. Chou, C. Miller, L. Blatnik, E. Wischhof, J. Bu, W. Mccarty, L. Guo, S. Nass, C. O'Riordan, B. Elmer, C. Mueller, S. Ramachandran (Waltham, USA)
Aberrant connectivity in Resting-State Brain Networks Underlying Neuropsychiatric Symptoms in Prodromal Lewy Body Dementia.

L. Wright, P. Donaghy, D. Burn, J-P. Taylor, J. O'Brien, A. Yarnall, F. Matthews, M. Firbank, H. Sigurdsson, J. Schumacher, A. Thomas, R. Lawson (Newcastle upon Tyne, United Kingdom)
Abnormal basal ganglia-related functional gradient in Parkinson’s disease

L. Chen, L. Sun, M. Xia, T. Wu (Beijing, China)
Abnormal brain iron metabolism influences neural function in isolated laryngeal dystonia

G. Battistella, L. Xavier, A. Vortmeyer, K. Simonyan (Boston, USA)
Abnormal Subthalamic Oscillations as Potential Biomarkers for Identifying the Dyskinesia-Inducing Region within the Subthalamic Nucleus in Parkinson’s Disease

J. Li, J. Wei, X. Jia, Y. Liang, Y. Zhang (beijing, China)
Abnormal Top-down Perceptual Modulation Drives Visual Hallucinations in Parkinson’s Disease

A. Cucca, M. Catalan, M. Liccari, TMI. Lombardo, V. Cenacchi, S. Rangan, CV. Manara, S. Mingolo, M. Murgia, T. Agostini, P. Manganotti (Trieste, Italy)
Abstract: Trends in Movement Disorders related death in the United States from 1999 to 2020

A. Khalid, L. Munir, A. Chaudhary, M. Ammar-Ur-Rahman, A. Alabedi (Lahore, Pakistan)
Acceptability and user experience of the electronic versions of the MDS-UPDRS and MDS-NMS scales

M. Monje, R. Fuller, T. Turner, L. Chahine, K. Dujardin, C. Fitzer-Attas, S. Groppa, S. Perez-Lloret, J. Youn, S. Ali, P. Martinez-Martin, G. Stebbins, T. Mestre, A. Sánchez-Ferro (Chicago, USA)
Acceptability of Digital Health Technologies in Early Parkinson’s Disease

T. Kangarloo, R. Latzman, J. Adams, E. Dorsey, M. Kostrzebski, D. Anderson, F. Horak, D. Stephenson, J. Cosman (Cambridge, USA)
AccessPD Registry Update: Accelerating Parkinson’s Disease Research Through Integrated Digital Solutions

Y-H. Chang, M. Periñan, A. Noyce (London, United Kingdom)
Accuracy of AI-driven automated diagnostic software analyzing Susceptibility Map-Weighted Imaging to Differentiate Neurodegenerative from Non-neurodegenerative Parkinsonism

E. Wallert, E. V.D. Giessen, M. Beudel, T. van Mierlo, J. Blankevoort, DH. Shin, R. de Bie, J. Booij (Amsterdam, Netherlands)
Accuracy of Clinical features for Substantia Nigra Hypopigmentation and Cortical Lewy Body Presence in the Oldest-Old: The 90+ Study

R. Rajmohan, Z. Al-Darsani, N. Phielipp, T. Montine, M. Corrada, C. Kawas (Orange, USA)
Acute and chronic effects of deep brain stimulation on gait in patients with Parkinson’s disease.

C. Buetefisch, F. Isbaine, J. Nocera, J. Tran, S. Triche, C. Esper, P. Aia, L. Scorr, L. Higginbotham, R. Tripathi, J. Mckay, S. Miocinovic (Atlanta, USA)
Acute Ataxia in children : a North-African Single Center Experience

S. Saad, H. Ben Rhouma, M. Jamoussi, T. Ben Younes, H. Klaa, Z. Miladi, A. Zioudi, I. Kraoua (Tunis, Tunisia)
Acute Chorea in The Emergency Department Related to Systemic Lupus and Antiphospholipid Syndrome: A Case Report

AS. Lima Verde, F. Rolim, G. Ferreira, PC. Matos, B. Abreu, JI. Landim, N. Frota, F. Carvalho, A. Marinho (Fortaleza, Brazil)
Acute dystonic dyskinesias in a patient used fluvoxamine. Case report

A. Katok, D. Khasanova, G. Ilina (Kazan, Russian Federation)
Acute effects of a multicomponent aquatic training session on heart rate variability in PD: a case study

A. Doliny, S. Souza, J. Siega, V. Israel (CURITIBA, Brazil)
Acute Reversible Laughter with Globus Pallidus Interna Stimulation

K. Nalamada, F. Isbaine, P. Aia, S. Miocinovic (Atlanta, USA)
Adaptive vs Conventional Chronic Deep Brain Stimulation: Results from a Randomized Pilot Trial in Parkinson’s Disease

I. Isaias, S. Marceglia, L. Romito, R. Eleopra, L. Borellini, V. Levi, M. Locatelli, T. Mandat, E. Pirola, A. Ampollini, M. Lanotte, L. Lopiano, M. Zibetti, A. Bentivoglio, C. Piano, A. Izzo, F. Tamma, G. Foffani, A. Lozano, E. Moro, J. Volkmann, C. Conti, M. Arlotti, L. Krinke, L. Rossi, A. Priori (Milan, Italy)
Adding Parkinsonism to the Phenotypic Spectrum of FIG4-related diseases

K. Pyle, G. Pawar, J. Frey (Morgantown, USA)
Addressing Patient Needs: Enhancing Patient-Centered Care at the Movement Disorders Center

M. Ivancic, A. Frohlich, W. Crutchfield, H. Morita, R. Murrow, J. Rider, D. Roque, M. Sklerov, C. Testa, J. Younce, N. Browner (Chapel Hill, USA)
Adherence and Persistence Among Patients with Parkinson’s Disease Initiating Istradefylline: 12-Month Follow-Up from US Real-World Data

R. Joseph, J. Qian, H. Cummings, Y. Chen, S. Tewari, M. Soileau (Columbus, USA)
Adult Onset Spastic Paraplegia in TUBB4A Leukodystrophy

HJ. Kim, HJ. Ha, CY. Lee, JY. Yun (Seoul, Republic of Korea)
Adult-onset Niemann-Pick C in India: phenotype and genotype

S. Bhowmick, J. Ganguly, D. Garg, V. Holla, P. Wadia, H. Shah, P. Shah (Vadodara, India)
Advancing Interpretability in Parkinson’s Disease Voice Analysis: A Multilingual AI Approach

M. Wójcik-Pędziwiatr, M. Zakrzewski, M. Wodziński, J. Orozco-Arroyave, E. Nöth, M. Rudzińska-Bar, D. Sztaho, T. Rumezak, D. Hemmerling (Kraków, Poland)
Advancing regulatory endorsed drug development tools in alignment with emerging biology: The Critical Path for Parkinson’s Consortium

D. Stephenson, C. Kopil, M. Müller, O. Mabrouk, H. Kocherla, R. Comley, K. Yee, T. Dam, G. Pagano, J. Seibyl, K. Marek, T. Simuni (Tucson, USA)
Aerobic Exercise in Non-Exercisers with Advanced Parkinson’s Disease (PD) and Deep Brain Stimulation (DBS): A Pilot Study

S. Aslam, M. Olson, S. Felson, F. Ponce, H. Shill (Aurora, USA)
Age and Parkinson’s disease: clinical and biomarkers profiling of younger and older patients

G. Di Lazzaro, F. Paolini Paoletti, G. Bellomo, T. Schirinzi, P. Grillo, G. Giuffrè, A. Picca, M. Petracca, AR. Bentivoglio, NB. Mercuri, L. Parnetti, P. Calabresi (Rome, Italy)
Age of Onset and Choice of First-line Therapy in Essential Tremor Patients

F. Jamal, G. Jackson, A. Sarwar, P. Mandava (Houston, USA)
Age of Onset and Non-Motor Symptoms in Early Parkinson’s Disease: A Data-Analysis Study Based on the Fox Insight Cohort

A. Oliveira Franco, D. Teixeira-Dos-Santos, A. Noyce, S. Bandres-Ciga, A. Schumacher Schuh (Porto Alegre, Brazil)
Age- and Sex-Associated Changes in the Behavior of Neuronal Mitochondria During Healthy Aging

E. Klinman, A. Yoo (St Louis, USA)
Age-associated Changes in Microglial Morphology and its Role in Deciphering Susceptibility to Parkinson’s Disease

S. Choudhury, P. Abhilash, P. Alladi (Bengaluru, India)
Age-associated presbyvestibulopathy is more severely abnormal in PD compared to the older controls

N. Bohnen, G. Carli, T. Brown, S. David, J. Barr, R. Vangel, T. Johnson, K. Kerber, D. Mccaslin (Ann Arbor, USA)
AI based longitudinal changes in substantia nigra contrast and volume on neuromelanin MRI and its relation to clinical markers in a multi-site Parkinson’s disease study.

M. Ingalhalikar, H. Pham, T. G, L. Bracoud, MH. Hutchison, K. Evans, T. Dam, KN. Nguyen, CC. Conklin, JS. Suhy, DS. Scott (San Mateo, USA)
AI for Personalized Medication Management in Parkinson’s Disease

R. Diaz-Rincon, H. Khoshbouei, B. Shickel (Gainesville, USA)
AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease

SB. Soumma, D. Peterson, H. Ghasemzadeh, S. Mehta (Tempe, USA)
AI-Powered Eyewear for Routine Facial Expression Analysis in Parkinson’s Disease: Study design and goals

H Y. Ooi, C. Zhang, K. Li, J. Narins, H. Sarva (New York, USA)
Alexander technique remote-delivery group course for people living with Parkinson’s improves motor plan assembly time with correlated improvement in function

M. Gross, R. Cohen, C. Condie (Candler, USA)
Alpha-synuclein affects PRMT5-mediated cytoprotective pathway in neuronally differentiated SH-SY5Y cell

T. Nakamura, N. Sugeno, T. Hasegawa, K. Ikeda, S. Yoshida, S. Ishiyama, K. Sato, A. Takeda, M. Aoki (Sendai, Japan)
Alpha-synuclein aggregate pathology in the cranial sensorimotor system in a mouse model of Parkinson’s disease.

A. Schaser (West Lafayette, USA)
Alpha-Synuclein and Mitochondria Quality Control in Parkinson’s Disease: A Literature Review

L. Shen (State College, USA)
Alterations in Monoamine Metabolites in Parkinson’s Disease: A Meta-Analysis

MA. Muneer, V. Suresh, E. Zulfiqar, S. Saaki, I. Jaffery, V. Chowdary, S. Hurjkaliani (Lahore, Pakistan)
Alterations in neural processes of cognitive control in asymptomatic heterozygous mutation carriers in the Parkin gene

J. Böhm, J. Uter, R. Lundin, J. Henkel, P. Pramstaller, C. Klein, A. Hicks, M. Heldmann, N. Brüggemann (Lübeck, Germany)
Alterations in the Daily Living Gait and Mobility during the Day and Night among Individuals with Cerebellar Ataxia, SCA3: An Exploratory Study

P. Ponger, A. Solomon, M. Brozgol, E. Gazit, J. Hausdorff (Tel Aviv, Israel)
Alterations of NAD metabolism in symptomatic and asymptomatic carriers of pathogenic GCH1 variant

J. Prasuhn, L. van Well, F. Hamami, C. Klein, A. Weissbach, N. Brüggemann (Lübeck, Germany)
Altered [18F]VAT Uptake Supports Cholinergic Dysfunction in Isolated Adult-Onset Cervical Dystonia

N. Goldman, J. O'Donnell, A. Tanenbaum, J. Lee, J. Perlmutter, S. Norris (St Louis, USA)
Altered activity of lysosomal hydrolases in monocyte-derived macrophages as potential biomarker for differential diagnosis of multiple system atrophy

K. Basharova, A. Bezrukova, G. Baydakova, I. Miliukhina, E. Zakharova, S. Pchelina, T. Usenko (Gatchina, Russian Federation)
Altered Dynamic Functional Connectivity in Parkinson’s Disease Individuals with Visual Hallucinations and Dysfunction

MA. Alizadeh, SN. Naghizadehkashani, OS. Shoraka, KS. Shivok, IF. Fayed, KH. Hines, AA. Atik, CM. Matias, RS. Sergott, TWL. Liang, CW. Wu (Philadelphia, USA)
Altered EEG Theta Activity Characterizes Parkinson’s disease with Levodopa-induced Dyskinesia

M. Sciascia, A. Castelnovo, I. Bertaina, C. Desperati, C. Steadler, A. Kaelin, S. Galati (Lugano, Switzerland)
Altered gut microbiota composition and metabolism in Parkinson’s disease

D. Mondhe, K. Roper, N. Jayabalan, J. O'Sullivan, R. Adam, A. Lehn, R. Gordon (Brisbane, Australia)
Altered levels of interleukin-6 in Parkinson’s disease patients with and without Covid-19

R. Matmurodov, B. Muminov, K. Khalimova (Tashkent, Uzbekistan)
Amyloid Pathology and its association with Cognitive Status in Huntington’s Disease

G. Olmedo Saura, J. Perez Perez, S. Martinez-Horta, A. Puig-Davi, A. Horta-Barba, A. Vazquez-Oliver, A. Campolongo, E. Rivas-Asensio, N. Salvat-Rovira, D. Alcolea, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)
An Analysis of Baseline Measures from a Diverse Parkinson’s Disease Interdisciplinary Clinic

V. Armengol, M. Feldman, M. Sarno, S. Marmol, A. Alfonso, G. Dumenigo, M. Garcia-Casals, S. Munzesheimer, A. Otto, TW. Siu, D. Yacinthe, D. Shpiner (Miami, USA)
An Innovative Approach Combining Transcranial Direct Current Stimulation and Speech Therapy for the Treatment of Dysphagia in Parkinson’s Disease.

T. Bocci, G. Cosentino, S. Pierro, E. Concas, C. Pipolo, E. Fuccillo, M. Guidetti, A. Priori (Milano, Italy)
An Investigation of Quality of Life for Caretakers of Parkinson’s Disease Patients in Indian Villages

S. Kuanar (BBSR, India)
An observational study of the efficacy, safety, and discontinuation rate of foslevodopa/foscarbidopa in 22 patients with advanced Parkinson’s disease

D. Kamiyama, N. Nishikawa, C. Abe, H. Iwaki, G. Oyama, T. Hatano, N. Hattori (Bunkyo, Japan)
An Unusual and Treatable Cause of Cerebellar Ataxia and Dystonia: Homozygous COQ4 Gene Mutation

T. Coradine, M. Soares, P. Fraiman, L. Corazza, T. Silva, J. Pedroso, O. Barsottini (Sao Paulo, Brazil)
Analgesic effect of electroacupuncture on Relieving pain in Parkinson’s disease and the mechanism based on rs-fMRI

JUN. Li (Hefei, China)
Analysing the bradykinesia features combination in people with Parkinson’s disease and elderly healthy individuals

G. Paparella, M. de Riggi, A. Cannavacciuolo, D. Costa, D. Birreci, M. Passaretti, L. Angelini, A. Berardelli, M. Bologna (rome, Italy)
Analysis of Patellar Reflex in Parkinson Disease Patients after an Acupuncture Treatment Protocol – Case Series Study

CRP. Pereira (Porto, Portugal)
Analysis of structural connectivity in relation to change in dopaminergic medication after 6 months of STN-DBS in Parkinson´s disease – a pilot study

š. Janovič, D. Kroneberg, B. Al-Fatly, A. Kušnírová, Z. Košutzká (Bratislava, Slovakia)
Anosognosia for hardware-related complications in deep brain stimulation

F. Wolff Fernandes, J. Runge, A. Saryyeva, JK. Krauss (Hannover, Germany)
Antibody-mediated movement disorders: a single-centre retrospective study

J. Moura, S. Costa, I. Carrilho, S. Figueiroa, P. Carneiro, E. Neves, J. Damásio, E. Santos, R. Samões (Porto, Portugal)
Antipsychotic Prescriptions Among Nursing Home Residents with Parkinson’s Disease in the End-of-Life Period

S. Berman, A. Willis, W. Aamodt (Philadelphia, USA)
Apathy in de novo Parkinson’s disease improves after the first years with dopaminergic treatment.

A. Castrioto, M. Anheim, E. Schmitt, S. Meoni, JL. Houeto, H. Klinger, D. Sourd, P. Pelissier, E. Lhommee, C. Tranchant, JP. Azulay, F. Durif, E. Moro, V. Fraix, S. Thobois, P. Krack (Grenoble, France)
Apathy produces selective deficits in cognitive function when controlling for depression in patients with Parkinson’s disease

G. Badwal, K. Patel, S. Pasternak, H. Ganjavi, R. Renwick, R. Camicioli, K. van Hedger, P. Macdonald (London, Canada)
Application of Neurophysiology in the Clinical Evaluation of Pediatric and Adolescent Patients with Tremor

B. Lavenstein, P. Mcgurrrin, F. Vial, E. Akano, S. Attaripour, P. Panyakaew, A. Choi, L. Pesantez-Pacheco, H. Lin, M. Hallett (Bethesda, USA)
Apraxia of eyelid opening in patients with movement disorders

H. Conn, A. Lenka, J. Jankovic (Houston, USA)
Artificial Intelligence and Visual Analysis of Movements in Parkinson’s Disease

T. Okelberry, H. Beisar, S. Horev, E. Pinchuk, K. Lyons, R. Pahwa (Kansas City, USA)
Artificial Intelligence Approaches for Tremor Detection and Classification from Hand-drawn Spirals

R. Rajan, R. Anandapadmanabhan, A. Vishnoi, V. Vishnu, D. Joshi, N. Kamble, V. Holla, P. James, G. Ram, B. Amulyavathi, D. Radhakrishnan, A. Srivastava, S. Krishnan, P. Pal, A. Mahabal (New Delhi, India)
Artificial Intelligence Opportunities for Diagnostics of Dementia via Speech (Brainphone Project)

I. Khasanov, D. Khasanova (Kazan, Russian Federation)
Artificial intelligence: a potential predictor of GBA1-mutated genotype in Parkinson’s Disease patients?

G. Di Rauso, A. Ghibellini, S. Grisanti, F. Cavallieri, V. Fioravanti, E. Monfrini, G. Toschi, G. Portaro, J. Rossi, R. Sabadini, L. Gherardini, C. Lucchi, G. Biagini, L. Bononi, M. Gabbrielli, A. Di Fonzo, F. Valzania (Reggio Emilia, Italy)
Assembling a Cohort of Hyposmic Participants for Therapeutic Studies Aimed at Parkinson’s Disease (PD) Prevention

B. Mcmahon, L. Lemon, R. Dobkin, E. Brown, J. Dimos, M. Kuhl, L. Heathers (Baltimore, USA)
Assessing a Video Based Approach at Measuring Parkinson’s Disease Severity – A Validation Study

BP. Bridges (St. John's, Canada)
Assessing Barriers to Advance Care Planning in Parkinson’s Disease Within a Cuban-American Population

T. Peabody, M. Abou-Ezzi, L. Hernandez, H. Moore, S. Vargas-Parra, A. Cruz, D. Shpiner (Miami, USA)
Assessing Executive Function in HD: Comparing the One Touch Stockings of Cambridge and Zindametrix’s Tower-Z as Components of the HD-CAB

M. Roche, G. Phelan, N. Sinha, A. Patel, A. Mansbach, H. Wilkinson, R. Fuller, J. Stout, S. Lazic, I. Antonijevic, S. Sathe, C. Sampaio (Princeton, USA)
Assessing Feasibility of Using Phone Video Data in Diagnosing Parkinsonism

Z. Ahmed, S. Desai, A. Deb, S. Roy, D. Desai (Worcester, USA)
Assessing Genome-wide Genetic Risk for Parkinson’s Disease in European Sub-Populations Across the Global Parkinson’s Genetics Program and National Biobanks

G. Lobal_parkinson'S_genetics_program (gp2) (Bethesda, USA)
Assessing the Accuracy of Clinical Diagnostic Criteria of Lewy Body Dementia for Detection of Lewy Body Disease in the Oldest-Old: The 90+ Study

R. Rajmohan, Z. Al-Darsani, N. Phielipp, T. Montine, M. Corrada, C. Kawas (Orange, USA)
Assessing the Accuracy of Clinical features, CSF Dopamine Metabolites, and Striatal Binding Ratios for the Likelihood of Depression Over 10-year Follow Up in the PPMI Cohort.

J. Li, A. Basu, C. Song, I. Bedoy, J. Ruiz Tejeda, S. Nguyen, R. Rajmohan, N. Phielipp (Irvine, USA)
Assessing the Economic Impact of Transcutaneous Afferent Patterned Stimulation Therapy for Essential Tremor: A Real-World Evidence Study Protocol

D. Dai, J. Fernandes, L. Samuel, C. Lu, S. Reitmaier, A. Berk (Woonsocket, USA)
Assessing the Impact of Deep Brain Stimulation on Cognitive Impairment in Parkinson’s Disease: a longitudinal study.

K. Velázquez-Román, G. Rivera-Monroy, R. Baños-Betancourt, W. Moguel-Cardín, A. Guerra-Anzaldo, C. álvarez-Hernández, A. Domínguez-García, A. Hernández-Medrano, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico city, Mexico)
Assessing the Predictive Accuracy of Baseline Neuropsychiatric and Axial Motor Features for Freezing of Gait in Parkinson’s Disease at 5-year Follow up: The PPMI Cohort

J. Li, R. Rajmohan, J. Ruiz Tejeda, N. Phielipp (Irvine, USA)
Assessment of Cerebellar Ataxia Severity in Patients with Posterior Cranial Fossa Tumors Using CASAS Scale

D. Khodjimetov (Tashkent, Uzbekistan)
Assessment of cognitive impairment in Parkinson’s disease in under-represented ethnic groups-The London-Dhaka Parkinson’s Cognitive Study

T. Zannat, KC. Dey, A. Zirra, A. Haque, E. Camboe, D. Mair, T. Haque, S. Waters, CR. Marshall, RS. Weil, S. Ali, N. Mukadam, AJ. Noyce, A. Habib (Dhaka, Bangladesh)
Assessment of Image-Guided Programming (IGP) in Bilateral STN and GPi Deep Brain Stimulation on Programming Time and Setting Outcomes

J. Aldred, T. Zesiewicz, M. Okun, L. Verhagen Metman, O. Vaou, C. Luca, R. Ramdhani, J. Durphy, Y. Bezchilbnyk, J. Carlson, K. Foote, S. Sani, A. Papanastassiou, J. Jagid, D. Weintraub, B. Reese, L. Chen, R. Shivacharan, E. Goldberg (Spokane, USA)
Assessment of Motor and Non-Motor Alterations Impacting Functionality in Parkinson’s Disease Patients

R. Dias, M. Piemonte, G. Gomes, L. Bitaraes (Sao Paulo, Brazil)
Assessment of pain in people with Parkinson’s disease: an exploratory survey of international nursing experiences

C. Tedesco, M. Petralito, R. Caruso, G. Pucciarelli (Rome, Italy)
Assessment Of The Effect Of Sleep Deprivation And Essential Amino Acid Deficient Diet (Tryptophan) On Growth And Cognition In Wistar Rats

L. Usman, R. Ibrahim, H. Abdulameed, E. Ajani, A. Akinmoladun (Kepala Batas, Malaysia)
Assessment of Visual Field in Patients with Moderate-to-Severe Parkinson’s Disease

S. Mehta, M. Syed, S. Naghizadehkashani, K. Shivok, L. Krisa, C. Matias, C. Wu, T. Liang, R. Sergott, M. Alizadeh (Philadelphia, USA)
Association between Antiepileptic Drugs and Parkinson’s Disease: A Strong or Weak Link?

S. Kharel, SS. Shrestha, SA. Acharya, R. Ojha (Kathmandu, Nepal)
Association Between Cerebral Glucose Metabolism and Amyloid Deposition in Parkinson’s Disease

HK. Na, Y. Sun, JH. Lee, CW. Park, YH. Sohn, CH. Lyoo, PH. Lee (Seoul, Republic of Korea)
Association Between Clinical Progression in Multiple System Atrophy and Brain Volume Changes Evaluated via Deep Learning Segmentation

D. Claassen, K. Hett, A. Brown, A. Wynn, C. Wallace, K. Rose, M. Bradbury, C. Wong, D. Stamler, P. Trujillo (Nashville, USA)
Association between Dipeptidyl Peptidase-4 Inhibitor Usage and Mortality in Parkinson’s Disease: a nation-wide study

M. Park, K. Baik, I. Hong, M. Baek (Gwangmyeong, Republic of Korea)
Association Between DPP-4 Inhibitors Use and Risk of Dementia: A Meta-analysis Using Real-world Data

S. Hussain (New Delhi, India)
Association between environmental phthalates exposure and gut microbiota and metabolome in dementia with Lewy bodies

J. Zou, Z. Deng, L. Li, J. Jing, X. Luo, F. Yu, W. Zeng, W. Bi (Guangzhou, China)
Association between Fecal Bile Acids and Levodopa Response in Patients with Parkinson’s Disease

XD. Yang, Q. Xiao, XQ. He (Shanghai, China)
Association between Genetic Polymorphisms and Disease Progression in Parkinson’s disease

TC. Fang, YJ. Guo, MH. Chang (Taichung, Taiwan)
Association Between Glycated Hemoglobin (HbA1c) Levels And Motor Symptoms In Indian Subjects With Parkinson’s Disease: A Cross Sectional Observational Study

NIK. Choudhary, NAV. Seervi, AMI. Bhargava, SHU. K (Jodhpur, India)
Association between Hyperglycemic Crisis Severity and Movement Disorders in Hispanic Patients with De Novo Hyperglycemia: A Cross-Sectional Study

D. Japón-Cueva, C. Rodriguez-Alarcon, A. Carofilis-Cornejo, L. Viñan-Paucar, M. Cueva-Espinoza, A. Benavidez-Lopez, P. Gruezo-Realpe, R. Santibanez-Vasquez (Guayaquil, Ecuador)
Association Between Hypertension Timing and Clinical Variables in Parkinson’s Disease: A Retrospective Analysis

WF. Moguel Cardín, AL. Guerra Anzaldo, GA. Espinosa Cruz, A. Adam Castro, A. Dominguez García, A. Cervantes Arriaga, M. Rodríguez Violante, AJ. Hernández Medrano, G. Rivera Monroy, K. Velázquez Román, RJ. Baños Betancourt, CF. álvarez Hernández, DP. Romero Terán, JC. Delgado Uriarte, NP. Moreno Aldama, MC. Unda Mcfarlane, A. Uribe León (Ciudad de Mexico, Mexico)
Association between Kinetic Parameters of Alpha-synuclein Seed Amplification Assay in CSF and Parkinson’s Disease Subtypes.

P. Grillo, G. Riboldi, A. Pisani, L. Concha, U. Kang (New York City, USA)
Association between Morbidity and Social Vulnerability in Patients with Huntington Disease

J. Patino, N. Rocha, S. Zadegan, B. Duncan, R. Ramphul, A. Sharrief, E. Furr Stimming (Houston, USA)
Association Between Motor Symptoms and Autonomic Dysfunction in De Novo Parkinson’s Disease: Insights into the Role of the Gut-Brain Axis

KY. Kwon, JE. Park (Seoul, Republic of Korea)
Association between Non-Motor Parkinson’s disease symptoms and hyposmia in a population-based cohort

C. Theyer, K. Marini, F. Krismer, C. Horlings, H. Stockner, K. Schwarzová, I. Egner, A. Djamshidian-Tehrani, M. Marti, R. Krüger, V. Satagopam, B. Mollenhauer, S. Schade, C. Trenkwalder, K. Rege, S. Ghosh, A. Garrido, E. Tolosa, T. Marques, D. Mcintyre, W. Poewe, K. Seppi, P. Mahlknecht (Innsbruck, Austria)
Association between Parkinsonism, Parkinson’s Disease and Cognitive Impairment and Incidence of Dementia in People with Parkinsonism and Parkinson’s Disease in Latin America: A 10/66 Dementia Research Group Study

N. Khan, M. Arruabarrena, D. Kim, M. Jiang, J. Llibre-Rodriguez, A. Salgado, I. Acosta, A. Sosa, D. Acosta, I. Jimenez-Velasquez, M. Guerra, A. Salas, L. Contreras, H. Hesse, C. Tanner, M. Prina, J. Guerra (Newcasle Upon Tyne, United Kingdom)
Association between statin use and mortality in Parkinson’s disease

M. Park, I. Hong, M. Baek (Gwangmyeong, Republic of Korea)
Association between use of Furosemide and Risk of Parkinson’s disease

B. Babar, AM. Tolppanen, S. Hartikainen, M. Tiihonen (Kuopio, Finland)
Association between Walking Pace, Brain Structure, and Risk of Parkinson’s Disease and Atypical Parkinsonism in the UK Biobank

S. Wang, Y. Xiao, X. Zheng, J. Liu, J. Lin, T. Yang, Q. Jiang, C. Li, H. Shang (Chengdu, China)
Association of Autonomic Symptoms with Motor Features of Parkinson’s Disease in the Nigeria Parkinson’s Disease Research Network Registry

E. Nwazor, O. Ojo, O. Agabi, N. Okubadejo, NPD. Research Network (Port Harcourt, Nigeria)
Association of cognition and other clinical characteristics of individuals with Essential Tremors

H. Khalil, M. Nazzal, A. Al-Sharman, D. Al-Shorafat, H. Al Refa’I, S. Obeidat, L. Samman, K. El-Salem (Doha, Qatar)
Association of expanded CAG repeat with autonomic function in Spinocerebellar Ataxia Type-2 (SCA-2)

A. Sonakar, F. Faruq, A. Srivastava (NEW DELHI, India)
Association of Gaucher-related and Parkinson’s-private GBA1 variants with progression of PD: A longitudinal mixed model analysis.

A-M. Hanff, C. Mccrum, A. Rauschenberger, S. Pachchek, G. Aguayo, C. Pauly, S. Jónsdóttir, O. Tsurkalenko, L. Pauly, Z. Landoulsi, A. Leist, P. May, M. Zeegers, R. Krüger (Strassen, Luxembourg)
Association of Impulse Control Disorder with GRIN2B Gene Polymorphisims in Parkinson Disease

G. Memari, E. Erzurumluoglu, N. Durmaz Celik, S. özkan, S. Artan (Eskisehir, Turkey)
Association of insomnia with levodopa-related parameters in Parkinson’s disease

L. Atabekyan, N. Nadryan, E. Balian, H. Karkourian, H. Hovakimyan, Z. Tavadyan, S. Khachatryan (Yerevan, Armenia)
Association of Liver Fibrosis with Motor Deficits in Parkinson’s Disease

A. Zolin, H. Ooi, H. Sarva (New York, USA)
Association of polygenic risk score of the LRRK2 gene for Parkinson’s disease with lysosomal hydrolase activities in the Russian Population based on genetic profile and established risk factors

T. Usenko, K. Basharova, A. Bezrukova, K. Senkevich, I. Miliukhina, A. Timofeeva, E. Zakharova, S. Pchelina (Gatchina, Russian Federation)
Association of Retinol Binding Protein (RBP) and the Risk of Parkinson’s disease (PD): A Narrative Literature Review

V. Sharma (Urban, India)
Association of Striatal Dopaminergic Depletion, Cerebral Perfusion, and Cognitive Outcome in Brain-first and Body-first Parkinson’s Disease

SH. Jeong, JS. Baik, PH. Lee, SJ. Chung (Seoul, Republic of Korea)
Association of β-Amyloid Load on PET with Cognitive Profiles Across the Lewy Body Diseases Continuum

KA. Woo, EJ. Yoon, SY. Kim, HJ. Kim, BR. Jin, SM. Lee, HW. Nam, HW. Park, YK. Kim, JY. Lee (Seoul, Republic of Korea)
Associations between Choroid Plexus and tau in Parkinson’s Disease

Z. Wang, J. Li, C. Cai, C. Jiang, L. Zhao (Hangzhou, China)
Associations Between Striatal Dopamine Transporter Binding and Motor Asymmetry In De Novo PD with and Without RBD

H. Hameed, S. Elasfar, K. Ehgoetz Martens (Waterloo, Canada)
Asymmetric Symptomatic Huntington’s Disease in a Patient with Intermediate Range Trinucleotide Repeats

D. Palanisamy, L. Hogan, C. Lim, S. Frank (Boston, USA)
Ataxia and Gait Improvement in Relapsing-Remitting Multiple Sclerosis After Transcranial Magnetic Stimulation (TMS): A Case Study

NA. Megayasa, A. Tiksnadi, D. Tunjungsari (Jakarta Pusat, Indonesia)
Ataxia and Parkinsonism Related with CAG Expansion Size in a Cohort of Huntington’s Disease in the Brazilian Amazon Region.

M. Della Coletta, C. Camargo, D. Brito, G. Benevides, C. Fantin, D. Cruz, M. Evangelista, F. Carvalho, M. Teles, D. Reis, E. Amaral, H. Teive (Manaus, Brazil)
Ataxia Telangiectasia Diagnosis in Lower-Middle-Income Countries: A Case Report

H. Ngo Thi, T. Nguyen Anh (Hanoi, Viet Nam)
Ataxia, tremor, fasciculations and hemiparesis in a GBA1 heterozygous female carrier

I. Sarac, H. Sarac, F. Borovečki, N. Henigsberg, I. Jurak, K. Zic (Zagreb, Croatia)
Ataxic-spastic gait: a form of presentation of DYT5/DYT-GCH1

V. Mendes Ferreira, M. Magriço, B. Meira, P. Bugalho (Lisboa, Portugal)
ATP1A3-related disorder overlapping syndrome: a case report

A. Santana, A. Azzoni, M. Sakuma, C. Gusmão (São Paulo, Brazil)
ATP8A2 Mutation in a Tunisian Family : Expanding The Clinical Spectrum

M. Ben Hafsa, H. Benrhouma, T. Ben Younes, R. Maroofian, H. Klaa, H. Houlden, I. Kraoua (Tunis, Tunisia)
Attention/Working memory and Executive Tests in Parkinson’s disease: Review, Critique and Recommendations

R. Biundo, O. Bezdicek, D. Cammisuli, B. Cholerton, JC. Dalrymple-Alford, N. Edelstyn, E. Fiorenzato, E. Holker, SI. Martinez-Horta, A. Martini, G. Santangelo, B. Segura, C. Siri, A. Troster, M. Skorvanek, D. Weintraub, G. Geurtsen (Padova, Italy)
Attitudes and Beliefs Towards Medication Burden and Deprescribing in Parkinson Disease

TP. Pham Nguyen, D. Thibault, A. Hamedani, A. Willis (Philadelphia, USA)
Atypical Parkinsonism Secondary to Recurrent Deep Vein Thrombosis with Associated Intracranial Dural Fistula

C. Gómez López-de-San-Román, DM. Cerdán Santacruz, M. Capra, L. Caballero Sánchez, I. Bermejo Casado, A. Castrillo Sanz, A. Mendoza Rodríguez, G. Suárez Fernández, P. Guerrero Becerra, M. Vargas Cobos, C. Tabernero Garcia (Segovia, Spain)
Atypical spinocerebellar ataxia (SCA) type 16 as initial presenting migraine and mild ataxia with cerebellar atrophy

W. Yoon (Seoul, Republic of Korea)
Augmented feedback during virtual reality training improves learning in people with Parkinson’s disease: A Single-Blind Randomized Clinical Trial

P. Igarasi Barbosa, A. Falconi, M. D'Alencar, E. Okamoto, M. Pimentel Piemonte (Sao Paulo, Brazil)
Autoimmune Movement Disorders: An Illustrative Case Series of 8 Patients.

P. Singh, A. Gupta, A. Gupta (Delhi, India)
Automated Imaging Differentiation of Parkinsonism (AIDP): A Prospective 21-site Trial within the Parkinson’s Study Group

D. Vaillancourt, A. Barmpoutis, R. Chen, J. Desimone, M. Schauder, W. Wang, T. Parish, R. Fang, M. Okun (Gainesville, USA)
Automated Selection of Deep Brain Stimulation (DBS) Parameters for Parkinson’s Disease (PD) Using Pallidal Local Field Potentials (LFP): A Prospective Pilot Study

J. Yu, T. de Araujo, J. Cagle, C. de Hemptinne (Gainesville, USA)
Automatic detection of Freezing of gait in Parkinson’s disease with IMU: validation of a deep learning algorithm in the home.

M. Goris, P. Yang, P. Ginis, B. Filtjens, B. Vanrumste, A. Nieuwboer, M. Gilat (Leuven, Belgium)
Autonomic dysfunction and its impact on quality of life in Mexican people living with PD

MF. Medina Pérez, D. Lopez Galindo, AJ. Hernandez Medrano, DP. Romero Terán, SF. Arechavala Lopez, G. Rivera Monroy, KI. Sanchez Ramirez, A. Abundes Corona, A. Cervantes Arriaga, M. Rodríguez Violante (Mexico, Mexico)
Autonomic Dysfunction in Parkinson’s Disease Link with disease severity and other non-motor signs

A. Mousli, R. Zouari, A. Rachdi, F. Nabli, D. Ben Mohamed, Z. Saeid, S. Ben Sassi (Ariana, Tunisia)
Autoradiography characterization of novel alpha-synuclein radioligands [3H]Tg1-90B, [3H]M503-1619 and [3H]HY-2-15 in human post mortem brain

D. Saturnino Guarino, G. Tian, K. Ho Young, H. Cj, V. Lee, K. Luk, R. Mach (Philadelphia, USA)
Autosomal recessive cerebellar ataxias: a Tunisian cohort of 168 patients

L. Hlioui, R. Zouari, R. Amouri, MZ. Saied, D. Ben Mohamed, A. Rachdi, S. Ben Sassi (Tunis, Tunisia)
Autosomal Recessive GTPCH Deficiency: Redefining the Phenotypic Spectrum and Outcome

M. Novelli, M. Tolve, V. Quiroz, C. Carducci, R. Bove, G. Ricciardi, C. Yang, F. Pisani, D. Ebrahimi-Fakhari, S. Galosi, V. Leuzzi (Rome, Italy)
Autosomal recessive spastic ataxia of Charlevoix–Saguenay: Case report with 3 family members affected.

H. Pacheco Mendoza, L. Nuñez Orozco, P. Briseño López, A. Negrete Gómez, J. Delgado Uriarte (Mexico, Mexico)
Autosomal Recessive Spastic Ataxia Secondary a Novel SPG7 Gene Pathogenic Variant: a Case Report

K. Salinas-Barboza, J. Altamirano, A. Armas-Salazar (CDMX, Mexico)
Axial Tremor does not correlate with Poor Balance in Essential Tremor

C. Flavin, E. Stulberg, M. Szilagyi, S. Rahimpour, P. Kassavetis (Salt Lake City, USA)